Skip to content
★ Sign in to follow
旭富

旭富 Stock: price and insider trades · Taiwan

TW·Mcap NT$6.3BHealth Care

旭富: what insiders have been doing

旭富 has a thin disclosure history in our data (latest filing: 7 July 2020). New filings will appear here as soon as they are published. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 19,645 of 26,911 companies
35.9
score / 100
Value
28
Quality
44
FCF yld-6.2%
Earn yld1.7%
EV/EBITDA20.2x
ROE1.1%
Gross mgn26%
Net mgn8.0%
Debt/EBITDA2.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$53
Analyst consensus
·
Income statement
RevenueNT$1.3B
Gross profitNT$351M26% margin
EBITDANT$360.1M27% margin
Net incomeNT$107.4M4.8% margin
Valuation
PER (trailing)103.1x
P/Book1.2x
Beta-0.00
Balance sheet & cash
Market capNT$6.3B
Total debtNT$987.2M
Free Cash Flow-NT$389.9M
Debt / Equity20%
Profitability & ownership
ROE1.1%
ROA0.9%
% insiders45.2%
% institutions0.5%
Last declaration on 7 July 2020
Declarations1 total
  • ●
    ManagerExecutives
    €321kest.0MOPS
    100,000 sharesShareTWSETWMOPS:4119:109/07/07:周文智:0twcme1

1 of 1 declaration

About 旭富

旭富 is a company listed on the XTAI market, specializing in the financial sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations